Presumed Roles of APRO Family Proteins in Cancer Invasiveness
- PMID: 36230852
- PMCID: PMC9564062
- DOI: 10.3390/cancers14194931
Presumed Roles of APRO Family Proteins in Cancer Invasiveness
Abstract
The APRO family members may be involved in the regulation of cell growth, migration, and/or invasion. Although an APRO protein could suppress the invasiveness of several cancer cells, it has been reported that overexpression of the same APRO protein could also promote the invasiveness and/or metastasis of the same cancer cells. In general, the invasiveness of cancer cells might be associated with the function of matrix metalloproteinases (MMPs) as well as with the function of certain exosomes. However, it has been shown that exosomes involving particular APRO proteins, MMPs, and/or microRNA could contribute to the regulation of invasiveness. Here, we discuss contradictory reports on invasiveness in relation to APRO family proteins on the basis of understanding the function of MMPs and/or various exosomes. A better understanding of those mechanisms could be of use to bring about innovative strategies for cancer treatment.
Keywords: APRO protein; exosome; matrix metalloproteinase; microRNA; tissue inhibitors of metalloproteinase.
Conflict of interest statement
The authors declare that they have no competing financial interests.
Figures


Similar articles
-
Expression and prognosis analyses of the Tob/BTG antiproliferative (APRO) protein family in human cancers.PLoS One. 2017 Sep 18;12(9):e0184902. doi: 10.1371/journal.pone.0184902. eCollection 2017. PLoS One. 2017. PMID: 28922388 Free PMC article.
-
The other side of MMPs: protective roles in tumor progression.Cancer Metastasis Rev. 2007 Dec;26(3-4):717-24. doi: 10.1007/s10555-007-9089-4. Cancer Metastasis Rev. 2007. PMID: 17717634 Review.
-
Matrix metalloproteinases and metastasis.Cancer Chemother Pharmacol. 1999;43 Suppl:S42-51. doi: 10.1007/s002800051097. Cancer Chemother Pharmacol. 1999. PMID: 10357558 Review.
-
[The role of metalloproteinases in modification of extracellular matrix in invasive tumor growth, metastasis and angiogenesis].Postepy Hig Med Dosw (Online). 2012 Sep 10;66:609-28. doi: 10.5604/17322693.1009705. Postepy Hig Med Dosw (Online). 2012. PMID: 23001203 Review. Polish.
-
Increased expression of matrix metalloproteinases mediates thromboxane A2-induced invasion in lung cancer cells.Curr Cancer Drug Targets. 2012 Jul;12(6):703-15. doi: 10.2174/156800912801784884. Curr Cancer Drug Targets. 2012. PMID: 22515524
Cited by
-
Fatty Acid Metabolites and the Tumor Microenvironment as Potent Regulators of Cancer Stem Cell Signaling.Metabolites. 2023 May 31;13(6):709. doi: 10.3390/metabo13060709. Metabolites. 2023. PMID: 37367867 Free PMC article. Review.
-
Potential tactics with vitamin D and certain phytochemicals for enhancing the effectiveness of immune-checkpoint blockade therapies.Explor Target Antitumor Ther. 2023;4(3):460-473. doi: 10.37349/etat.2023.00145. Epub 2023 Jun 30. Explor Target Antitumor Ther. 2023. PMID: 37455830 Free PMC article.
-
Promising roles of vitamin D receptor and APRO family proteins for the development of cancer stem cells targeted malignant tumor therapy.Oncol Res. 2025 Apr 18;33(5):1007-1017. doi: 10.32604/or.2025.059657. eCollection 2025. Oncol Res. 2025. PMID: 40296902 Free PMC article. Review.
-
A pan-cancer analysis of anti-proliferative protein family genes for therapeutic targets in cancer.Sci Rep. 2023 Dec 7;13(1):21607. doi: 10.1038/s41598-023-48961-1. Sci Rep. 2023. PMID: 38062199 Free PMC article.
-
Non-Coding RNAs and Gut Microbiota in the Pathogenesis of Cardiac Arrhythmias: The Latest Update.Genes (Basel). 2023 Aug 30;14(9):1736. doi: 10.3390/genes14091736. Genes (Basel). 2023. PMID: 37761875 Free PMC article. Review.
References
-
- Guéhenneux F., Duret L., Callanan M.B., Bouhas R., Hayette S., Berthet C., Samarut C., Rimokh R., Birot A.M., Wang Q., et al. Cloning of the mouse BTG3 gene and definition of a new gene family (the BTG family) involved in the negative control of the cell cycle. Leukemia. 1997;11:370–375. doi: 10.1038/sj.leu.2400599. - DOI - PubMed
-
- Matsuda S., Kawamura-Tsuzuku J., Ohsugi M., Yoshida M., Emi M., Nakamura Y., Onda M., Yoshida Y., Nishiyama A., Yamamoto T. Tob, a novel protein that interacts with p185erbB2, is associated with anti-proliferative activity. Oncogene. 1996;12:705–713. - PubMed
-
- Ikematsu N., Yoshida Y., Kawamura-Tsuzuku J., Ohsugi M., Onda M., Hirai M., Fujimoto J., Yamamoto T. Tob2, a novel anti-proliferative Tob/BTG1 family member, associates with a component of the CCR4 transcriptional regulatory complex capable of binding cyclin-dependent kinases. Oncogene. 1999;18:7432–7441. doi: 10.1038/sj.onc.1203193. - DOI - PubMed
-
- Buanne P., Corrente G., Micheli L., Palena A., Lavia P., Spadafora C., Lakshmana M.K., Rinaldi A., Banfi S., Quarto M., et al. Cloning of PC3B, a novel member of the PC3/BTG/TOB family of growth inhibitory genes, highly expressed in the olfactory epithelium. Genomics. 2000;68:253–263. doi: 10.1006/geno.2000.6288. - DOI - PubMed
LinkOut - more resources
Full Text Sources